Suraj Saksena

PhD, EMBA

Role: Universal Diagnostics s a at Universal Diagnostics S.A.
Location: San Jose, CA, US
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

About Suraj Saksena

CLIA High Complexity Lab Director (NRCC-Certified Clinical Chemist). EMBA from…

Experience

Universal Diagnostics s a
Universal Diagnostics S.A.
Present

Education

Quantic School of Business and Technology
Executive MBA
University of Delhi South Campus
MS, Biochemistry
1998 — 2000
University of Delhi
BS, Biochemistry
1995 — 1998
Texas A&M University
PhD, Biochemistry & Biophysics
2000 — 2005

Skills

Recombinant Dna Technology
High-Performance Liquid Chromatography (Hplc)
Molecular Biology
Clinical Development
Western Blotting
Polymerase Chain Reaction (Pcr)
Drug Discovery
Monoclonal Antibodies
Lifesciences
Purification
Protein Expression
Immunology
Assay Development
Protein Chemistry
Product Management
International Political Economy
Cell
Pcr
Cell Culture
Validation
In Vitro
Hplc
Political Economy
Laboratory
Oncology
Enzyme Assays
Fluorescence Spectroscopy
Life Sciences
Biochemistry
Biotechnology
Protein Purification
Research and Development (R&D)
Laboratory Automation
Genomics
Biomarkers
R&D
High Throughput Screening
Biophysics
Antibodies
Recombinant Dna

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
s••••••••@universaldx.com
Personal email
•••••@•••••.com
Direct dial
+18•••••••05

Unlock verified contacts

Free to start · No credit card required

Current company

Universal Diagnostics S.A.

Biotechnology · 132 employees · Founded 2012 · Sevilla, Andalucia, Spain

Universal Diagnostics S.A. (UDX) is a Spanish in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early. The UDX diagnostic platform is designed to detect various cancer types, e.g. colorectal, prostate, liver, pancreatic lung, breast cancer (>50% of all new cancer cases p.a.) via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis. UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I). To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.

universaldx.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Suraj Saksena

Experience

Universal Diagnostics s a

Education

Quantic School of Business and Technology

University of Delhi South Campus

University of Delhi

Texas A&M University

Skills

Find verified contacts for anyone on LinkedIn